Four unrelated patients having an unusual clinical phenotype, including multiple peripheral nerve sheath tumors, are reported. Their clinical features were not typical of any known familial tumor syndrome. The patients had multiple painful neurofibromas, including bilateral orbital plexiform neurofibromas, and spinal as well as mucosal neurofibromas. In addition, they exhibited a marfanoid habitus, shared similar facial features, and had enlarged corneal nerves as well as neuronal migration defects. Comprehensive NF1, NF2 and SMARCB1 mutation analyses revealed no mutation in blood lymphocytes and in schwann cells cultured from plexiform neurofibromas. Furthermore, no mutations in RET, PRKAR1A, PTEN and other RAS-pathway genes were found in ...
BACKGROUND: Neurofibromatosis type 1 (NF-1) is an autsomal dominant disorder which can occasionally...
Patients with neurofibromatosis 1 (NF1) develop multiple neurofibromas, with 8% to 15% of patients e...
A Thai woman, who was affected with neurofibromatosis type 1, was followed up and re-evaluated at ag...
Four unrelated patients having an unusual clinical phenotype, including multiple peripheral nerve sh...
Plexiform neurofibromas are classically thought to be pathognomonic for neurofibromatosis type 1. Ho...
The commonest tumors associated with neurofibromatosis type 1 (NF1) are benign peripheral nerve shea...
Neurofibromatosis 1 (NF1) is an autosomal dominant disease. Neurofibromas, benign tumours that devel...
We report 4 cases of malignant peripheral nerve sheath tumors (MPNST) with neurofibromatosis type 1 ...
Benign peripheral nerve sheath tumors (PNSTs) are a characteristic feature of neurofibromatosis type...
Malignant peripheral nerve sheath tumours (MPNSTs) are a malignancy occurring with increased frequen...
Malignant peripheral nerve sheath tumors (MPNSTs) are rare sarcomas that are strongly associated wit...
BackgroundNeurofibromatosis 1 (NF1) leads to the development of benign and malignant peripheral nerv...
Introduction: Neurofibromatosis includes a group of genetic diseases that cause tumors affecting ner...
Neurofibromatosis 1 (NF1) leads to the development of benign and malignant peripheral nerve sheath t...
Objective Neurofibromatosis type 1 (NF1) patients have a 13% risk of developing a malignant perip...
BACKGROUND: Neurofibromatosis type 1 (NF-1) is an autsomal dominant disorder which can occasionally...
Patients with neurofibromatosis 1 (NF1) develop multiple neurofibromas, with 8% to 15% of patients e...
A Thai woman, who was affected with neurofibromatosis type 1, was followed up and re-evaluated at ag...
Four unrelated patients having an unusual clinical phenotype, including multiple peripheral nerve sh...
Plexiform neurofibromas are classically thought to be pathognomonic for neurofibromatosis type 1. Ho...
The commonest tumors associated with neurofibromatosis type 1 (NF1) are benign peripheral nerve shea...
Neurofibromatosis 1 (NF1) is an autosomal dominant disease. Neurofibromas, benign tumours that devel...
We report 4 cases of malignant peripheral nerve sheath tumors (MPNST) with neurofibromatosis type 1 ...
Benign peripheral nerve sheath tumors (PNSTs) are a characteristic feature of neurofibromatosis type...
Malignant peripheral nerve sheath tumours (MPNSTs) are a malignancy occurring with increased frequen...
Malignant peripheral nerve sheath tumors (MPNSTs) are rare sarcomas that are strongly associated wit...
BackgroundNeurofibromatosis 1 (NF1) leads to the development of benign and malignant peripheral nerv...
Introduction: Neurofibromatosis includes a group of genetic diseases that cause tumors affecting ner...
Neurofibromatosis 1 (NF1) leads to the development of benign and malignant peripheral nerve sheath t...
Objective Neurofibromatosis type 1 (NF1) patients have a 13% risk of developing a malignant perip...
BACKGROUND: Neurofibromatosis type 1 (NF-1) is an autsomal dominant disorder which can occasionally...
Patients with neurofibromatosis 1 (NF1) develop multiple neurofibromas, with 8% to 15% of patients e...
A Thai woman, who was affected with neurofibromatosis type 1, was followed up and re-evaluated at ag...